Hypercoagulability in kidney transplant recipients

Sandesh Parajuli, Joseph B. Lockridge, Eric D. Langewisch, Douglas J. Norman, Jody L. Kujovich

Research output: Contribution to journalReview article

18 Scopus citations

Abstract

Thrombosis remains an important complication after kidney transplantation. Outcomes for graft and deep vein thrombosis are not favorable. The majority of early kidney transplant failure in adults is due to allograft thrombosis. Risk stratification, early diagnosis, and appropriate intervention are critical to the management of thrombotic complications of transplant. In patients with end-stage renal disease, the prevalence of acquired risk factors for thrombosis is significantly high. Because of hereditary and acquired risk factors, renal transplant recipientsmanifest features of a chronic prothrombotic state. Identification of hereditary thrombotic risk factors before transplantation may be a useful tool for selecting appropriate candidates for thrombosis prophylaxis immediately after transplantation. Short-term anticoagulation may be appropriate for all patients after kidney transplantation.

Original languageEnglish (US)
Pages (from-to)719-726
Number of pages8
JournalTransplantation
Volume100
Issue number4
DOIs
StatePublished - Jan 1 2016

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Hypercoagulability in kidney transplant recipients'. Together they form a unique fingerprint.

  • Cite this

    Parajuli, S., Lockridge, J. B., Langewisch, E. D., Norman, D. J., & Kujovich, J. L. (2016). Hypercoagulability in kidney transplant recipients. Transplantation, 100(4), 719-726. https://doi.org/10.1097/TP.0000000000000887